Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06395662 · ClinicalTrials.gov registry record

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.

A clinical trial of Multiple Sclerosis and Radiologically Isolated Syndrome, sponsored by Centre Hospitalier Universitaire de Nīmes.

Active
Registry status
320
Enrollment target
3
Study locations

NCT06395662 is a study of Multiple Sclerosis and Radiologically Isolated Syndrome that is active but no longer recruiting, run by Centre Hospitalier Universitaire de Nīmes. The registered enrollment target is 320 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (45% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06395662, a study of Multiple Sclerosis and Radiologically Isolated Syndrome, is active but no longer recruiting, sponsored by Centre Hospitalier Universitaire de Nīmes.

ACTIVE NOT RECRUITING
Registry status
320 participants
Enrollment target
3
Study locations

Study Summary

Radiologically isolated syndrome (RIS) often precedes Multiple Sclerosis (MS) but some patients have no symptoms. This study aims to use biological samples and magnetic resonance imaging (MRI) data from four large cohorts of patients with MS in the United States, Europe and France, to stratify the chances of RIS developing into MS. Identifying early biomarkers to predict greater disease severity would have a significant impact, not only on RIS but also on the entire clinical spectrum of multiple sclerosis.

Conditions Studied

Multiple Sclerosis Radiologically Isolated Syndrome

Interventions

  • OTHER Observational

Study Locations (3)

Texas

  • University of Texas, Southwestern - Dallas

Alpes-Maritimes

  • COTE D'AZUR UNIVERSITY, URRIS-UR2CA. Hôpital Pasteur 2, 30, Voie Romaine - Nice

Rhône

  • INTERNATIONAL CENTER OF RESEARCH IN INFECTIOLOGY, LYON UNIVERSITY, INSERM U1111, CNRS UMR 5308, ENS, UCBL 46 Allée d'Italie - Lyon

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2024-04-15
Est. Completion 2025-07

Sponsor

Centre Hospitalier Universitaire de Nīmes

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06395662

The ClinicalTrials.gov registry entry for NCT06395662 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (45% lower). The listed sponsor is Centre Hospitalier Universitaire de Nīmes, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT06395662 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Texas, Alpes-Maritimes, Rhône.

Frequently Asked Questions

What is clinical trial NCT06395662 about?

NCT06395662 is a clinical study titled "Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.". Radiologically isolated syndrome (RIS) often precedes Multiple Sclerosis (MS) but some patients have no symptoms. This study aims to use biological samples and magnetic resonance imaging (MRI) data from four large cohorts of patients with MS in the United States, Europe and France, to stratify the c...

What is the current status of trial NCT06395662?

This trial is currently active not recruiting. The enrollment target is 320 participants. The study started on 2024-04-15. Estimated completion is 2025-07.

What conditions does trial NCT06395662 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Radiologically Isolated Syndrome.

What interventions are being tested in trial NCT06395662?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT06395662?

This trial is sponsored by Centre Hospitalier Universitaire de Nīmes, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06395662 being conducted?

This trial has 3 study locations across Texas, Alpes-Maritimes, Rhône. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Radiologically Isolated Syndrome

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.